GUELPH, ON, Aug. 28 /CNW/ - BIOREM Inc. ("Biorem") (TSX-V: BRM) announced
today it will be showcasing its new Unity product line at an event at the
Preston Wastewater Treatment Facility in Cambridge, Ontario, on Friday, August
28, 2009. The event will be hosted by Ontario's Ministry of Research and
Innovation, which has provided Biorem with almost $1.2 million in new funding
through its Innovation Demonstration Fund ("IDF"). IDF is a discretionary,
non-entitlement funding program administered by the Ministry that focuses on
the commercialization and initial technical demonstration of globally
competitive, innovative Green technologies, processes and/or products.
"The new funding provided by the Ontario's Ministry of Research and
Innovation will allow us to showcase two different odour control projects:
Unity, which is a small footprint unit that is shipped to site, already
pre-assembled and requires minimal set-up on-site, and; a larger capacity
unit, which is built on-site. We are currently evaluating locations for a
demonstration site for this larger unit," said Peter Bruijns, President and
"Advanced product development efforts via focused
commercialization-oriented research are a constant priority at Biorem," added
Mr. Bruijns. "This process technology provides us with a competitive advantage
in both international markets such as China, but also in large city
applications where footprint is a real constraint. This technology although
developed for odour control also has great potential in green-house gas
About BIOREM Inc.
Biorem designs and manufactures air pollution control systems, including
biofiltration and biotrickling systems that safely remove harmful contaminants
such as Hydrogen Sulfide, Reduced Sulfur compounds, and VOC's from the air.
Our systems are environmentally friendly, clean and sustainable all the while
reducing green-house gas emissions. With more than 600 installed systems
worldwide, continued extensive research efforts and over 15 years of
experience, Biorem not only offers state of the art technology based products
but also peace of mind for municipalities and industrial companies and their
surrounding communities. Additional information on Biorem is available at our
web site at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements based on current
expectations. These forward-looking statements contain various risks and
uncertainties that could cause actual results to differ materially from those
reflected in the forward-looking statements. Risks and uncertainties about the
Company's business are more fully discussed in the disclosure materials,
financial statements and MD&A filed with the securities regulatory authorities
in Canada on www.sedar.com.
"Order Bookings" and "Order Backlog" do not have any standardized meaning
prescribed by Canadian generally accepted accounting principles ("GAAP") and
may not be comparable to measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the Company
uses to evaluate its sales performance. Order Bookings are those binding
contracts that the Company enters into with a third party for the delivery of
our products or services. As Order Bookings are received, the contract value
(before any associated sales taxes) is included in the Order Backlog. The
Order Backlog is reduced by the revenue that is recognized on each project.
For further information:
For further information: Ed Corbett, Chief Financial Officer, BIOREM
Technologies Inc., firstname.lastname@example.org, Tel: (519) 767-9100 x275; Adriana
Braczek, Investor Relations, The Equicom Group Inc.,
email@example.com, Tel: (416) 815-0700 x240